• 26TH JULY 2024

    CPCF Negotiations: Update in light of new Government

    Community Pharmacy England has been continuing to make the case for the community pharmacy sector following the General Election, but negotiations are not expected to resume before September. In the first weeks of the new Government urgent representations have been made to the Department of Health and Social Care (DHSC) and NHS England on the

    Read more
    • 25TH JULY 2024

    NHSBSA ‘Hints & Tips’ – Issue 56

    The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 55) contains some useful information and advice on: Prescription switching – reduce the chances of it happening to you NHS Prescription Prepayment Certificates (PPC) Medicines covered by the Hormone Replacement Therapy Prescription Prepayment Certificate

    Read more
    • 25TH JULY 2024

    MHRA Class 4 Medicines Defect Information: Co-trimoxazole 80mg/400mg per 5ml adult suspension (Aspen Pharma Trading Limited)

    Class 4 Medicines Defect Information: Co-trimoxazole 80mg/400mg per 5ml adult suspension (Aspen Pharma Trading Limited) Drug alert number: EL (24)A/32 Date issued: 25 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Co-trimoxazole 80mg/400mg per 5ml adult suspension (Aspen Pharma Trading Limited) Company name: Aspen

    Read more
    • 25TH JULY 2024

    July 2024 Price Concessions 2nd Update

    Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (25/07/2024) announced the following list of price concessions for July 2024: Drug Pack size Price concession Agomelatine 25mg tablets 28 £13.50 Amisulpride 200mg tablets 60 £28.42 Betamethasone valerate 0.1%

    Read more
    • 23RD JULY 2024

    MHRA Drug Safety Update: July 2024

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 12 July 2024) has been published and includes articles on: Epimax Ointment and Epimax Paraffin-Free Ointment: reports of ocular surface toxicity and ocular chemical injury Letters and medicine recalls sent to healthcare professionals in June 2024. To see the latest

    Read more